Skip to content

Mitochondrial Complex 2 Deficiency Nuclear Type 2 C5436933

Published: July 22, 2026Updated: August 20, 2026

A rare metabolic disorder affecting energy production in cells, potentially causing neurological and physical symptoms. It varies in severity and often appears in childhood. Treatment is supportive and focuses on symptom management.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Developmental delay

(neurological)

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Dystonia

(neurological)

Ataxia

(neurological)

Cardiomyopathy

(cardiovascular)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Coenzyme Q10 Supplementation

Ubiquinone supplementation to bypass complex II deficiency and support mitochondrial electron transport. Often combined with other electron carriers.

medication
2

Medication management with follow-up care

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Ketogenic Diet

High-fat, low-carbohydrate diet that provides alternative energy substrates through ketone body metabolism, potentially bypassing defective complex II.

dietary

Additional treatment options

Riboflavin and B-Vitamin Complex

FAD precursor supplementation supports flavoprotein function including succinate dehydrogenase (complex II) activity. May improve electron transfer efficiency.

medication

Muscle Conditioning Program

Gentle resistance training and aerobic exercise adapted to individual capacity helps maintain muscle mass and function while avoiding overexertion.

physical_therapy

Multisystem Function Monitoring

Regular assessment of cardiac, neurological, and muscular function through echocardiography, EEG, and laboratory markers to track disease progression.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Mitochondrial Complex 2 Deficiency Nuclear Type 2 C5436933?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Mitochondrial Complex 2 Deficiency Nuclear Type 2 C5436933. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy